GOLIM4 and neoplasm: Following CRISPR/Cas-9-mediated GOLIM4 depletion (Supplemental Figure 1E), 344SQ cells exhibited reduced proliferative and migratory activity in culture and decreased tumor growth and metastatic activity in mice (Figure 2K and Supplemental Figure 1, F and G).